Stanley T. Lewis, MD, MPH

Company: A28 Therapeutics

Job title: Founder, Chief Executive Officer

Seminars:

Hormone-Peptide Conjugate: Next Generation Targeted Therapy 9:00 am

Explore a paradigm shift in conjugate design, focusing on the mechanism rather than the molecule, to unlock new avenues for targeted therapy innovations Embrace innovation, this conjugate design bypasses traditional linker-based approaches, with the hormone directly fused to the lytic peptide, optimizing delivery and enhancing therapeutic efficacy Discover how the unique design of hormone-linked lytic…Read more

day: Conference Day 1